Aridis Pharmaceuticals, Inc.
ARDSDelisted Sep 8, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001614067
Aridis Pharmaceuticals, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Jun 28, 2024; 18 institutions reported holding it in 13F filings for Q2 2023, worth $392.3K in total; no superinvestor held it.
13F holders, Q2 2026
Institutional positions in Aridis Pharmaceuticals, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
ARDS is no longer listed, and 13F filings after Q2 2023 list far fewer holders. See Q2 2023
- Institutional holders
- 1
- 0 vs. Q1 2026
- Shares held
- 3.00K
- 0 (0.0%) vs. Q1 2026
- Total value
- $0
- −$1 (−100.0%) vs. Q1 2026
- New holders
- 0
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARDS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $1 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $3 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 2 | $10 |
| Q3 2023 | 1 | $1.44K |
| Q2 2023 | 18 | $392.3K |
| Q1 2023 | 20 | $1.29M |
| Q4 2022 | 17 | $4.58M |
| Q3 2022 | 16 | $1.79M |
| Q2 2022 | 19 | $2.05M |
| Q1 2022 | 22 | $3.38M |
| Q4 2021 | 20 | $2.96M |
| Q3 2021 | 18 | $7.33M |
| Q2 2021 | 13 | $7.87M |
| Q1 2021 | 12 | $5.97M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Aridis Pharmaceuticals, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Strengthening Families & Communities, LLC | 3,000 | $0 | 0.00% | 00.0% | Unchanged |